Abstract Details
|
Shuait Nair
PRESENTER |
Mr. Nair has nothing to disclose. |
| Michael Kinkata, MD | Michael Kinkata, MD has nothing to disclose. |
| Alana Snyder, MSPH | Miss Snyder has nothing to disclose. |
| Stanley Zimba, MBBS (University Teaching Hospital) | Dr. Zimba has nothing to disclose. |
| Musisye Luchembe | Musisye Luchembe has nothing to disclose. |
| Deanna Saylor, MD, MHS, FÂé¶¹´«Ã½Ó³» (Johns Hopkins Hospital) | Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Âé¶¹´«Ã½Ó³». The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from Âé¶¹´«Ã½Ó³». Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Âé¶¹´«Ã½Ó³»al Innovation Commitees with American Neurological Association that is relevant to Âé¶¹´«Ã½Ó³» interests or activities. |